Early ultrasound evaluation for prediction of treatment response to neoadjuvant chemotherapy in triple negative breast cancer patients

被引：0
|
作者：
Adrada, B. E. [1 ]
Candelaria, R. [1 ]
Moulder, S. [1 ]
Lane, D. [1 ]
Santiago, L. [1 ]
Arribas, E. [1 ]
Hess, K. R. [1 ]
Valero, V. [1 ]
Thompson, A. [1 ]
Helgason, T. [1 ]
Ravenberg, E. [1 ]
Yang, W. [1 ]
Rauch, G. M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P6-02-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-02-10
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER
    Atalay, Can
    Karaman, Niyazi
    Yilmaz, Kerim Bora
    Altinok, Mehmet
    JOURNAL OF BREAST HEALTH, 2007, 3 (01): : 26 - 30
  • [42] Pembrolizumab in the neoadjuvant Treatment of early triple-negative Breast Cancer
    Dierks, Friederike
    Pietsch, Elisabeth
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 841 - 843
  • [43] Genomic profile and response prediction of eribulin mesylate-based neoadjuvant chemotherapy in triple-negative breast cancer patients
    Nishimura, T.
    Masuda, N.
    Kawaguchi, K.
    Takada, M.
    Maeshima, Y.
    Tanaka, S.
    Velaga, R.
    Kikawa, Y.
    Kadoya, T.
    Bando, H.
    Nakamura, R.
    Yamamoto, Y.
    Ueno, T.
    Yasojima, H.
    Ishiguro, H.
    Morita, S.
    Ohno, S.
    Haga, H.
    Ogawa, S.
    Toi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S424 - S425
  • [44] Survival Outcome of Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Early Triple Negative Breast Cancer
    Huang, Kai
    Jakub, James W.
    Gabriel, Emmanuel
    Moreno-Aspitia, Alvaro
    McLaughlin, Sarah
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S120 - S120
  • [45] 18F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen
    Groheux, David
    Biard, Lucie
    Giacchetti, Sylvie
    Teixeira, Luis
    Hindie, Elif
    Cuvier, Caroline
    Vercellino, Laetitia
    Merlet, Pascal
    de Roquancourt, Anne
    de Cremoux, Patricia
    Resche-Rigon, Matthieu
    Espie, Marc
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (04) : 536 - 543
  • [46] Identification of biomarkers including 18FDG-PET/CT for early prediction of response to neoadjuvant chemotherapy in Triple Negative Breast Cancer
    Humbert, O.
    Riedinger, J.
    Charon-Barra, C.
    Berriolo-Riedinger, A.
    Desmoulins, I.
    Lorgis, V.
    Kanoun, S.
    Coutant, C.
    Fumoleau, P.
    Brunotte, F.
    Cochet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S248 - S248
  • [47] Gene signature-based prediction of triple-negative breast cancer patient response to Neoadjuvant chemotherapy
    Zhao, Yanding
    Schaafsma, Evelien
    Cheng, Chao
    CANCER MEDICINE, 2020, 9 (17): : 6281 - 6295
  • [48] Development of DNA methylation markers panels for neoadjuvant chemotherapy response prediction in triple-negative breast cancer
    Sigin, V. O.
    Kalinkin, A. I.
    Ignatova, E.
    Chesnokova, G.
    Vinogradov, I. Y.
    Vinogradov, I. I.
    Vinogradov, M. I.
    Strelnikov, V. V.
    Zaletaev, D. V.
    Tanas, A. S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1225 - S1225
  • [49] A priori Prediction of Neoadjuvant Chemotherapy Response and Survival in Breast Cancer Patients using Quantitative Ultrasound
    Tadayyon, Hadi
    Sannachi, Lakshmanan
    Gangeh, Mehrdad J.
    Kim, Christina
    Ghandi, Sonal
    Trudeau, Maureen
    Pritchard, Kathleen
    Tran, William T.
    Slodkowska, Elzbieta
    Sadeghi-Naini, Ali
    Czarnota, Gregory J.
    SCIENTIFIC REPORTS, 2017, 7
  • [50] A priori Prediction of Neoadjuvant Chemotherapy Response and Survival in Breast Cancer Patients using Quantitative Ultrasound
    Hadi Tadayyon
    Lakshmanan Sannachi
    Mehrdad J. Gangeh
    Christina Kim
    Sonal Ghandi
    Maureen Trudeau
    Kathleen Pritchard
    William T. Tran
    Elzbieta Slodkowska
    Ali Sadeghi-Naini
    Gregory J. Czarnota
    Scientific Reports, 7
12345